The selected 299 mutations cover the National Comprehensive Cancer Network (NCCN) guideline of colon cancer recommended gene list relevant to treatment and prognosis, such as KRAS, NRAS, BRAF V600E mutations [15–17]. The gene discussed is BRAF; the disease is malignant colon neoplasm.